We found that the therapeutic effects of the various treatment groups on tumor growth inhibition and mouse survival displayed similar trends (Figures 2D, E) that mirrored the magnitude of CD8+ T cell responses (Figure 2C). The gene discussed is CD8A; the disease is neoplasm.